Clinical Research Directory
Browse clinical research sites, groups, and studies.
Target-specific immunoPET Imaging of Breast Cancer
Sponsor: RenJi Hospital
Summary
The aim of this study is to establish and optimize the Trop2/HER2-targeted PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agents in breast cancer will be evaluated.
Official title: Development and Clinical Translation of immunoPET Imaging Probes for Breast Cancer
Key Details
Gender
FEMALE
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2024-09-21
Completion Date
2026-11
Last Updated
2026-01-27
Healthy Volunteers
No
Interventions
[18F]F-RESCA-RT4
Enrolled patients will receive 0.05-0.1mCi/kg of \[18F\]F-RESCA-RT4. ImmunoPET/CT imaging will be acquired 1 hour after \[18F\]F-RESCA-RT4 injection.
[18F]F-RESCA-RB14
Enrolled patients will receive 0.05-0.1mCi/kg of \[18F\]F-RESCA-RB14. ImmunoPET/CT imaging will be acquired 1 hour after \[18F\]F-RESCA-RB14 injection.
Locations (1)
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China